It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Continuous variables are presented as median (IQR) and categorical variables are presented as number and percentage Primary Secondary Unknown p value Odds Ratio (95% CI) N = 105 N = 144 N = 44 (36%) (49%) (15%) Age (years) 13 (10.0–16.0) 14 (11.0–19.0) 14 (12.0–19.8) < 0.001 1.11 (1.05–1.17) Sex (% male) 79 (75) 76 (53) 35 (79) < 0.001 2.79 (1.61–4.83) Day of fever at enrolment, Number (%) 1 6 (6) 5 (4) 4 (9) 0.1 2 51 (49) 54 (38) 19 (43) 3 45 (43) 82 (57) 21 (48) 1.40 (0.94, 2.10) 4 2 (2) 3 (2) 0 (0) 5 1 (1) 0 (0) 0 (0) Serotype Number (%) 1 75 (71) 55 (38) 8 (18) < 0.001 – 2 18 (17) 40 (28) 17 (40) 3.03 (1.57–5.84) 3 9 (9) 13 (9) 7 (15) 1.96 (0.79–4.91) 4 3 (3) 36 (25) 12 (27) 16.36 (4.79–55.88) P-values are for comparisons between primary and secondary infections, using univariate logistic regression The kinetics of the antibody responses by illness day by immune status are shown in Fig. 2. The 1.4 cut-off used by Kuno is the same as the value we estimate on Day4, and the 1.2 used by Shu falls between our estimates from Day5 and Day6. [...]application of Innis’ algorithm overestimates secondary infections from Day2 onwards, while both Kuno and Shu algorithms overestimate primary infections early in illness, and overestimate secondary infections later in illness. [...]we chose to use PRNTs 6 months after infection as the gold standard for developing the models, not HI during infection as has been used conventionally in previous studies. [...]we gratefully acknowledge all the patients and their families for participating in this study.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer